SCOLR Pharma, Inc. Starts CDT(R)-Fenofibrate Testing

BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) announced today that it has commenced pilot bioavailability testing in Canada of its immediate release CDT®-fenofibrate tablets. Results from the trial are expected in late 2007.